Searched for
MAXIVISION FUNDING
Neuberg Diagnostics said to eye $350 million India IPO in 2026Neuberg Diagnostics is reportedly planning a $350 million IPO next year, joining India's booming stock market. Founder GSK Velu also intend...
ASG Eye Hospitals to merge with Sharp Sight in Rs 450 crore deal; PE-backed chain targets IPOASG Eye Hospitals, backed by General Atlantic and Kedaara Capital, has agreed to a ₹450 crore non-binding merger with Sharp Sight Eye Hospi...
Quadria Capital weighs Encube sale, keeps public float option alive, tooQuadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...
Quadria's third fund nets $1 billion, to deploy 60% in IndiaQuadria Capital, an Asia healthcare-focused private equity firm, has successfully raised $1.07 billion for its third fund, surpassing its i...
Quadria Capital to pick up minority stake in drug company AragenQuadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...
Kotak Pre-IPO fund to buy into diagnostic chain NeubergKotak Pre IPO Opportunities Fund is in advanced talks to acquire a 15% stake in Neuberg Diagnostics for approximately Rs 450 crore. Neuberg...
Verlinvest leads race for minority stake in Eye FoundationVerlinvest is poised to acquire a 20% stake in Eye Foundation for approximately $100 million, valuing the Indian eye hospital chain at Rs. ...
TA Associates, 2 others offer to buy into Eye FoundationTA Associates, Multiples PE, and KKR have made non-binding offers to invest ₹830 crore for a 25% stake in Eye Foundation, valuing it at ₹3,...
Founder Sachdev to retain majority stake in Centre for SightThe Padma Shri awardee, who previously headed the ophthalmology department at All India Institute of Medical Sciences, told ET that he woul...
ChrysCapital to invest Rs 830 cr in Centre For Sight, to pick Mahindra Holdings' entire stakeChrysCapital, a domestic PE fund, is set to invest up to Rs 830 crore in New Delhi's Centre for Sight (CFS), a leading eye care chain, part...
Neuberg Diagnostics plans to raise $100 million to fund acquisitionsNeuberg, which runs a pan-India diagnostic chain, has appointed O3 Capital as the investment banker and is currently in talks with potentia...
Quadria in talks to buy into dialysis chain NephroPlusQuadria Capital, an Asia-focused private equity fund, is in talks to acquire a significant minority stake in India's largest dialysis chain...
Sonia Dasgupta on three significant trends in the private equity market in 2023Emergence of the Healthcare sector: India has seen an increase in investments in the hospitals/healthcare sector (Rs 39,000 crore)in 2023 a...
Eye care industry at inflection point, boom in M&A activity likelyThe M&A boom could witness the emergence of four or more large players who could collectively own over 2000 eye hospitals in the next five ...
Maxivision plans to raise $100 millionThe Hyderabad-based company has appointed investment bankers and plans to complete the fund raise process by the end of March 2023. GSK Vel...
TPG in advanced talks to acquire 40% in Dr Agarwal's Health CareFounded by Dr Jaiveer Agarwal in 1957, Dr Agarwals Eye Hospital is the largest network of eye care centres in the country with more than 10...
Entrepreneur Velu back in diagnosticsThe re-entry puts him in direct competition with his former partner, Ameera Shah.
Healthcare entrepreneur G S K Velu readies Rs 500 crore early-stage fundThe yet-to-be-named proprietary investment management entity follows his recent exit from one of the companies, Metropolis Laboratories.
Carlyle may end Metropolis feud with Rs 900 crore stake buyMetropolis s today a multinational chain with more than 125 laboratories, tracking Rs 600-crore revenue annually.